Man Group’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.13M | Sell |
85,838
-102,946
| -55% | -$2.45M | ﹤0.01% | 1552 |
|
|
2025
Q4 | $4.41M | Sell |
188,784
-275,218
| -59% | -$6.13M | 0.01% | 1139 |
|
|
2025
Q3 | $9.14M | Buy |
464,002
+33,098
| +8% | +$681K | 0.02% | 838 |
|
|
2025
Q2 | $9.35M | Buy |
430,904
+135,162
| +46% | +$3.19M | 0.02% | 805 |
|
|
2025
Q1 | $7.17M | Sell |
295,742
-20,075
| -6% | -$452K | 0.02% | 862 |
|
|
2024
Q4 | $6.59M | Buy |
315,817
+61,123
| +24% | +$1.31M | 0.02% | 907 |
|
|
2024
Q3 | $5.06M | Sell |
254,694
-215,150
| -46% | -$3.99M | 0.01% | 1022 |
|
|
2024
Q2 | $7.28M | Sell |
469,844
-149,567
| -24% | -$2.33M | 0.02% | 844 |
|
|
2024
Q1 | $9.87M | Sell |
619,411
-24,805
| -4% | -$374K | 0.03% | 705 |
|
|
2023
Q4 | $10.8M | Buy |
+644,216
| New | +$8.81M | 0.03% | 602 |
|
|
2023
Q3 | – | Sell |
-835,008
| Closed | -$11.2M | – | 711 |
|
|
2023
Q2 | $11.2M | Buy |
+835,008
| New | +$12M | 0.03% | 584 |
|
|
2023
Q1 | – | Sell |
-889,532
| Closed | -$14.7M | – | 428 |
|
|
2022
Q4 | $16.5M | Buy |
889,532
+102,432
| +13% | +$1.58M | 0.06% | 398 |
|
|
2022
Q3 | $10.1M | Buy |
+787,100
| New | +$9.33M | 0.05% | 471 |
|
|
2022
Q2 | – | Sell |
-256,100
| Closed | -$1.88M | – | 1115 |
|
|
2022
Q1 | $2.12M | Sell |
256,100
-136,800
| -35% | -$967K | 0.01% | 1203 |
|
|
2021
Q4 | $2.66M | Buy |
392,900
+87,000
| +28% | +$572K | 0.01% | 1094 |
|
|
2021
Q3 | $1.62M | Hold |
305,900
| – | – | 0.01% | 1225 |
|
|
2021
Q2 | $1.76M | Sell |
305,900
-58,327
| -16% | -$301K | 0.01% | 1258 |
|
|
2021
Q1 | $1.68M | Sell |
364,227
-629,335
| -63% | -$2.5M | 0.01% | 1162 |
|
|
2020
Q4 | $3.32M | Sell |
993,562
-141,500
| -12% | -$475K | 0.01% | 994 |
|
|
2020
Q3 | $3.37M | Buy |
1,135,062
+85,327
| +8% | +$334K | 0.01% | 1003 |
|
|
2020
Q2 | $4.85M | Buy |
1,049,735
+941,435
| +869% | +$4.23M | 0.02% | 678 |
|
|
2020
Q1 | $417K | Buy |
108,300
+34,500
| +47% | +$142K | ﹤0.01% | 1322 |
|
|
2019
Q4 | $277K | Buy |
+73,800
| New | +$345K | ﹤0.01% | 1689 |
|
Other funds holding CPRX
VCM
DM
VPM